1α,25-Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells
- 26 October 1981
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 102 (3) , 937-943
- https://doi.org/10.1016/0006-291x(81)91628-4
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- 1,25-DIHYDROXYVITAMIN D3AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTUREEndocrinology, 1981
- Specific binding of 1,25 dihydroxyvitamin D3 in the VX2 carcinomaBiochemical and Biophysical Research Communications, 1980
- Studies of the internalization of vitamin D3 metabolites by cultured osteogenic sarcoma cells and their application to a non-chromatographic cytoreceptor assay for 1,25-dihydroxyvitamin D3Biochemical and Biophysical Research Communications, 1980
- 1,25-dihydroxyvitamin D3 receptor in a cultured human breast cancer cell line (MCF 7 cells)Biochemical and Biophysical Research Communications, 1980
- Induction of morphological and functional differentiation of human promyelocytic leukemia cells (HL‐60) by compounds which induce differentiation of murine leukemia cellsInternational Journal of Cancer, 1980
- Control of normal cell differentiation and the phenotypic reversion of malignancy in myeloid leukaemiaNature, 1978
- Basic and Clinical Concepts Related to Vitamin D Metabolism and ActionNew England Journal of Medicine, 1977
- Continuous growth and differentiation of human myeloid leukaemic cells in suspension cultureNature, 1977
- Induction of specific changes in the surface membrane of myeloid leukemic cells by steroid hormonesInternational Journal of Cancer, 1975
- Differentiation of a cell line of myeloid leukemiaJournal of Cellular Physiology, 1969